Additionally, nonsynonymous mutations and indels in protein-coding genes create tumor neoantigens (TNAs) in addition to the normal antigens of pulmonary parenchyma cells and mesenchymal cells, which can be recognized and killed by tumor-specific CD8+ cytotoxic T lymphocytes (CTLs). This evidence concerns the gene CD8A and neoplasm.